Rats emit aversive taste reactivity (TR) behavior (i.e., gapes) following intraoral delivery of a cocainepaired taste cue and greater conditioned aversive TR at the end of training predicts greater drug-seeking and taking. Here, we examined the development of this conditioned aversive TR behavior on a trial-by-trial basis in an effort to determine when the change in behavior occurs and whether early changes in this behavior can be used to predict later drug taking. The results show that conditioned aversive TR to a cocaine-paired cue occurs very early in training (i.e., following as few as 1-2 taste-drug pairings) and, importantly, that it can be used to predict later drug seeking and drug taking in rats.
of abuse such as morphine, cocaine, or heroin (either experimenter-or self-administered). Following repeated daily pairings, rats come to avoid intake of the saccharin cue in anticipation of drug availability relative to intake by saccharin-saline paired controls. This paradigm has, in fact, been studied for decades (Cappell & LeBlanc, 1971; Le Magnen, 1969) , but was quickly interpreted as a conditioned taste aversion akin to that induced by the illness-inducing agent LiCl (Davis & Riley, 2010; Lester, Nachman, & Le Magnen, 1970) , and, as such, as evidence for aversive drug properties. We reinterpreted these data and hypothesized that rats avoid intake of the saccharin cue, at least in part, because the taste cue pales in perceived value relative to the potent drug of abuse expected in the very near future (Grigson, 1997) . While the paradigm is more complex than originally thought (see below), evidence is available in support of this devaluation hypothesis in rats (see Grigson, 2008 for a review) and in man. For example, in humans, the caudate has been shown, using fMRI, to be less responsive to losses or gains in monetary reward when the subject is waiting to smoke (Wilson et al., 2013) .
In addition to drug-induced devaluation of the natural reward cue, however, we also have accumulated evidence suggesting that rats avoid the drug-paired gustatory cue because it comes to elicit the onset of a conditioned aversive state that may involving craving and withdrawal. Thus, like conditioned withdrawal (McDonald, Parker, & Siegel, 1997; Nunez, Foldes, Laorden, Milanes, & Kovacs, 2007; Shaham, & Stewart, 1995) , avoidance of the taste cue also is accompanied by elevated levels of circulating corticosterone (Gomez, Leo, & Grigson, 2000) , blunted (Grigson & Hajnal, 2007) or even reversed (i.e., reduced below baseline) (Wheeler et al., 2011 ) levels of accumbens dopamine, and the onset of aversive taste reactivity (TR) behavior (e.g., gapes) following the intraoral delivery of the drug-paired taste cue (Wheeler et al., 2008) . It is important to note that greater avoidance of the taste cue (Grigson & Twining, 2002; Twining, Bolan, & Grigson, 2009) , and a greater reduction in accumbens dopamine (Wheeler et al., 2011) , reliably predict greater drug taking in rats. This makes sense, as drug-taking would serve as the most effective "correction" for cue-induced withdrawal.
Responsiveness to the natural reward cue, then, provides information about who will take drug, when, and how much. In all cases described, save one (Grigson & Hajnal, 2007) , both the rats and the humans tested have been well experienced with drug. This is true for the assessment of aversive taste reactivity behavior (i.e., gapes). Thus, in our previous experiment (Wheeler et al., 2008) , the intraoral (IO) delivery (once/min/30 min) of one taste cue [referred to as the conditional stimulus (CS)ϩ] was paired with the opportunity to self-administer cocaine (0.33 mg/inf) for 2 h, and, on alternating days, the IO infusion of another taste cue (the CSϪ) was paired with the opportunity to self-administer saline for 2 h. Taste reactivity behavior was measured at the end of training and showed that the IO infusion of the CSϩ, but not the CSϪ, elicited strong aversive TR behavior (i.e., gapes). Moreover, a higher frequency of gapes elicited by the CSϩ (i.e., greater aversion) was associated with a shorter end of study latency to take drug, greater within-session cocaine load-up behavior, and faster acquisition of steady state responding for cocaine. Importantly, in this 2008 study, as alluded to, all TR behavior was measured only at the end of training, after 8 to 15 taste-drug pairings. In a more recent manuscript (Wheeler et al., 2011) , aversive TR was assessed after five pairings. In the present report, however, we did not simply want to correlate aversive taste reactivity behavior with drug self-administration behavior after the fact. To the contrary, we examined aversive taste reactivity behavior on a trial-by-trial basis beginning with the first cue-drug pairing. The goal here was to determine whether early changes in this conditioned behavior could predict later drug seeking and drug taking. Identification of an early indicator of vulnerability will allow for a better assessment of the development of the process of addiction in real time and will reveal a window for early intervention.
Method Subjects
The subjects were 21 adult male Sprague-Dawley rats obtained from Charles River (Wilmington, MA). They weighed between 304 and 612 g at the beginning of the experiment. The first replication included 13 rats; the second replication included 8. They were housed individually in standard, metal cages in a temperature-controlled (21°C) animal care facility with a 12-hr light-dark cycle (lights on at 7 a.m.). All experimental manipulations were conducted during the light phase of the cycle. The rats were maintained with free access to water and to dry Purina rodent diet 5001, except where noted otherwise.
Surgery
Self-administration catheter. Intrajugular catheters were custom made in our laboratory as described previously (Puhl, Blum, Acosta-Torres, & Grigson, 2012; Puhl, Cason, Wojnicki, Corwin, & Grigson, 2011; Twining et al., 2009) . General maintenance of catheter patency involved daily examination and flushing of catheters with heparinized saline. Catheter patency was verified as necessary using 0.2 ml of propofol (Diprivan 1%) administered intravenously.
Intraoral cannulas. PE 100 tubing (Intramedic, Sparks, MD) was cut into 8-cm segments, phalanged at one end, and fitted with a nylon washer (Grill & Norgren, 1978a , 1978b Wheeler et al., 2011 Wheeler et al., , 2008 . Cannulas were maintained by daily examination and flushing with distilled water.
Procedure. In preparation for surgery, rats were anesthetized with intramuscular (IM) ketamine (70 mg/kg) and xylazine (14 mg/kg). Each rat received 22,000 IU/kg of subcutaneous (SC) Gpenicillin at the beginning of the surgical procedure, and 10 ml SC saline when complete. For each rat, a catheter was implanted in the right external jugular vein as described. The IO cannulas were implanted bilaterally as described (Grill & Norgren, 1978a , 1978b Wheeler et al., 2011 Wheeler et al., , 2008 . Specifically, the tubing was inserted subcutaneously lateral to the first maxillary molar and secured with a nylon washer (.065 ID, .187 OD, .015 T, Product Components Corp.) between the molar and the cheek. The cannula was then secured at the excision point on the top of the head with a PTFE (Small Parts) washer, VetBond (3M Animal Care), and superglue (Loctite 409). When righting reflexes had recovered, rats were returned to their home cages with mash and solid chow available ad lib. Rats recovered for 17-20 days (first replication) or 33 days (second replication) before habituation began. During this time, solid chow and water were available ad lib, and nutritional support (e.g., SC fluids) was provided as needed.
Apparatus. Each rat was trained in one of four identical operant chambers (MED Associates, St. Albans, VT). Each chamber measures 29.3 cm in length ϫ 24.0 cm in width ϫ 27.0 cm in height, and is individually housed in a light-and sound-attenuated cubicle. The floor and back wall are clear Plexiglas; the side walls are aluminum. Each chamber is equipped with three retractable sipper spouts that enter through 1.3-cm diameter holes, spaced 16.4 cm apart (center to center). A stimulus light is located 6.0 cm above each tube. Each chamber also is equipped with a houselight (25 W), a tone generator (Sonalert Time Generator, 2900 Hz, Mallory, Indianapolis, IN), and a speaker for white noise (75 dB). Cocaine reinforcement is controlled by an infrared motion detector circuit that monitors nosepokes on an empty spout to operate a syringe pump (Model PHM-100VS, MED Associates, St. Albans, VT). A coupling assembly attaches the syringe pump to the catheter assembly on the back of each rat and enters through a 5.0-cm diameter hole in the top of the chamber. This assembly consists of a metal spring attached to a metal spacer with Tygon tubing inserted down the center, protecting passage of the tubing from rat interference. The tubing is attached to a five-channel counterbalanced swivel assembly (Instech, Plymouth Meeting, PA) that, in turn, is attached to the syringe pump. An angled mirror is located below the floor, allowing for a view of the ventral surface of the rat. Video is collected with a high-speed camera (100 frames/sec) positioned below the floor of the chamber that recorded orofacial responses following intraoral infusion of the gustatory stimuli (Basler). For the first replication, lighting for video was provided by four fluorescent lights (two at 9W and two at 8W) located below the chamber. For the second replication, lighting for video was provided by two fluorescent lights (each 8W) located below the chamber and a green panel light (0 -500 lux; CleverSys, Inc., Reston, VA) that served as the chamber's ceiling. Events in the chamber and collection of data were controlled online with a Pentium computer that used programs written in the Medstate notation language (MED Associates). This document is copyrighted by the American Psychological Association or one of its allied publishers.
This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
Conditioning Procedures
Water training. Ad lib water was removed 9 hours into the light phase of the last recovery day. For the next 8 days, rats were trained to drink from a bottle at the front of the home cage. Distilled water was available for 15 minutes each morning, beginning 2 hours into the light phase and for 1 hour each afternoon, beginning 6 hours into the light phase.
Habituation. Thereafter, beginning 2 hours into the light phase, rats received one 10-min chamber habituation session daily for 3 days. During this 10-min period, water was available, with the location of the spout varied across location 1-3 (left, middle, right). Each day rats were give overnight access to 20 ml distilled water at the front of the home cage, beginning about 75 minutes after being returned from the chamber to their home cage. This water restriction regimen continued throughout testing.
Cocaine self-administration. Using a within-subjects design, self-administration sessions consisted of a 30-min IO infusion period during which IO infusions of the tastant (CSϩ or CSϪ, 0.186% grape or orange unsweetened Kool-Aid in 0.15% saccharin, with flavors counterbalanced between rats) were delivered at a rate of one infusion (0.2 ml delivered over 3.5 s) per minute for 30 min. Thereafter, the middle and right empty spouts advanced and completion of a fixed number (FR1 on Trials 1-4; FR5 on Trials 5-16; FR10 on Trials 17-30) of contacts on the active (right) empty spout led to an intravenous infusion of saline on CSϪ trials or 0.33 mg/infusion cocaine on CSϩ trials for a 90 min (replication 1) or a 120 min (replication 2) access period. Each infusion was followed by a 20-s time-out period, during which the cue light was turned off, the house light was illuminated, the spouts were retracted, and a tone sounded. Contacts on the inactive middle spout were recorded, but were without consequence. There were a total of 15 such CSϩ trials and 15 CSϪ trials (see Figure 1 ).
In most cases (i.e., 17/21), training began with a CSϩ trial, as this order supported faster acquisition. Video was recorded only during intraoral infusion periods throughout the experiment. Therefore, the chamber lights were on during the I/O period, but were manually turned off at the beginning of the selfadministration period (the bright lights appeared to inhibit responding). Rats had overnight access to 20 ml of distilled water at the front of the home cage beginning about 45 minutes after being returned from the operant chamber.
Data Analysis
At the end of the study, gapes were scored manually by a reviewer blind to rat identity and tastant. Dependent measures included: the number of gapes emitted to the CSs, the latency to the first response on the active and the inactive spout, the number of responses emitted on the active and inactive spout, the latency to the first infusion, the number of load-up infusions, and the total number of infusions/session. A log10 transformation was used for the latency data to minimize the impact of a few extreme scores. Load-up was operationally defined as the number of infusions taken at interinfusion intervals less than the mean interinfusion interval for the session. Thereafter, the data for each trial were analyzed using 2 ϫ 15 mixed factorial analysis of variance (ANOVAs) varying group (high vs. low drug takers) and trial (1-15) and, where relevant, a 2 ϫ 30 mixed factorial ANOVA varying group and CS infusion period (1-30).
The Group ϫ Trials interactions rarely attainted statistical significance, likely because differences between low and high drug takers emerged early and were sustained across trials. As a consequence, only significant interactions are described below, followed by post hoc Student Newman-Keuls tests with p Ͻ .05. Further, because the primary objective of this study was to determine the point of emergence of conditioned aversive taste reactivity behavior to the drug-paired CSϩ solution, planned t tests were conducted on a trial-by-trial basis for each measure between the high and low drug takers. Statistical procedures were performed in Statistica7 (StatSoft) and SPSS 20 (IBM). Drug selfadministration behavior will be discussed first, followed by taste reactivity behavior emitted following IO delivery of the gustatory cue.
Results
Six rats were excluded from the first replication and three were excluded from the second replication because of health issues or loss of intravenous catheter or IO cannula patency. The final number of rats included in the analyses was seven from replication 1 and five from replication 2, for a total of 12.
Terminal Cocaine Infusions
As shown in Figure 2 , rats were divided into two groups, high and low drug takers, based upon the number of cocaine infusions taken during terminal CSϩ Trials 14 and 15. As has been reported previously, these subjects fell into distinct groups, with high drug takers clearly taking significantly more cocaine during the last two taste-drug pairings than low drug takers (13.25 Ϯ 4.25 vs. 0.58 Ϯ .08 infusions per session, F 2,9 ϭ 8.74; p Ͻ .01).
Cocaine Self-Administration Behavior
Having segregated rats by the number of infusions taken at the end of the study, we compared their other operant behaviors in an effort to fully characterize the behavior of these two groups of subjects. As described, following the overall ANOVA, responding by the high and low drug takers was compared on a trial-by-trial basis using planned t tests to determine the point at which differences in behavior emerged. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
Latency to first response on the active spout. A repeatedmeasures ANOVA of the log10 response latencies revealed a significant main effect of group, with high drug takers initiating contact with the active spout more quickly than low drug takers, overall, F 10,1 ϭ 6.67; p Ͻ .05; Figure 3A . The results of independent sample t tests at each trial indicated that high drug takers initiated licking on the active spout with a significantly shorter latency than low drug takers on Trial 8, t(10) ϭ 2.38, p Ͻ .05; Figure 3B .
Number of responses on active spout. A repeated-measures ANOVA of the number of responses on the active spout indicated a significant main effect of group, F 10,1 ϭ 71.60; p Ͻ .001. Thus, as shown in Figure 3C , high drug takers made more responses on the active spout, overall, than did low drug takers. The main effect of trial also was significant, F 140,14 ϭ 1.79; p Ͻ .05, indicating that the number of active responses increased across trials. According to the results of independent sample t tests, the high drug takers emitted significantly more responses on the active spout than the low drug takers, beginning with Trial 5, ps Ͻ .05 ( Figure 3D ).
Latency to first cocaine infusion. A repeated-measures ANOVA of the infusion log10 latency revealed significant main effects of group, F 10,1 ϭ 11.96, p Ͻ .01; Figure 3E , and trial, F 140,14 ϭ 2.94; p Ͻ.001. These results showed that high drug takers initiated their first infusion earlier in the session than the low drug takers. The Group ϫ Trial interaction did not attain statistical significance, F Ͻ 1. Comparison of the means on each trial ( Figure 3F ) using planned independent sample t tests indicated that high drug takers initiated their first infusion of cocaine significantly earlier than low drug takers on Trials 8, t 10 ϭ 4.05, p ϭ .01; 9, t 10 ϭ 2.43, p Ͻ .05; 13, t 10 ϭ 4.85; p Ͻ .01; and 14, t 10 ϭ 5.16, p Ͻ .001.
Number of cocaine load-up infusions. As shown in Figure  3G , high drug takers also engaged in higher levels of cocaine self-administration early in the session (i.e., they exhibited greater load-up behavior) than did the low drug takers. Support for this conclusion is provided by a significant main effect of Group (F 10,1 ϭ 6.20; p ϭ .03). There also was a significant main effect of trial and a significant Group ϫ Trial interaction (F 140,14 ϭ 2.29, p Ͻ .01). A similar pattern was evidenced on Trials 8 and 9 with follow-up independent sample t tests (ps Ͻ .05).
Total number of cocaine infusions. Finally, a repeatedmeasures ANOVA of the total number of cocaine infusions taken per trial across the 15 trials ( Figure 3I ) revealed a significant main effect of Group (F 10,1 ϭ 15.86, p Ͻ .003), with high drug takers self-administering more cocaine than low drug takers over the course of the study overall. The main effect of trial (F 140,14 ϭ 1.5, p ϭ .12) and the Group ϫ Trial interaction (F 140,14 ϭ 1.05, p ϭ .40) did not attain significance. Analysis of the individual trials using students t tests indicated that high drug takers took significantly more cocaine infusions than low drug takers on Trial 2 and on Trials 6 -15, ps Ͻ .05 ( Figure 3J ). It is important to note that while the high drug takers took more drug than the low drug takers on several trials (see Figure 3J ), correlational analyses revealed that the number of cocaine infusions self-administered early in training (i.e., on Trials 1-8) failed to predict terminal (i.e., mean of last two CSϩ trials) cocaine infusions (ps Ͼ.05).
Saline self-administration behavior. To test whether behavioral differences between high and low drug takers for cocaine carried over to saline in this within subjects design, we examined performance by these same subjects when responding for saline on CSϪ trials (data not shown). Unlike responding for cocaine, the results revealed that neither the main effect of group nor the Group ϫ Trials interaction was significant when considering the log10 latency to make the first active spout response for a saline infusion, the number of active spout responses emitted, the log10 latency to elicit the first saline infusion, and the total number of saline infusions elicited, ps Ͼ 0.05. That said, students t tests of the Group ϫ Trials interactions did show that high drug takers initiated responding for saline more quickly than low drug takers on at least one trial and took more saline infusions on two trials, ps Ͻ .05. Even so, when averaged across trials, responding for saline was quite low (high drug takers: 5.15 Ϯ 2.49; low drug takers: 1.36 Ϯ 0.37). Group differences in active spout responding, then, were fairly selectively driven by cocaine.
Taste Reactivity
According to Wheeler et al. (2008) , aversive taste reactivity to the CSϩ, but not to the CSϪ, following 8 -15 taste-drug pairings corresponded to a shorter latency to take drug, increased load-up, and an increase in the total number cocaine infusions. In contrast to the cited study, which assessed taste reactivity only at the end of training, here we measured aversive taste reactivity behavior (gapes; Figure 4A ) on every trial in an effort to monitor how a rat's evaluation of the tastants changed with experience and whether early changes in such behavior could be used to predict later drug seeking and drug taking.
Across-trial analysis of aversive taste reactivity. The number of gapes emitted by low and high drug takers was assessed across CSϩ or CSϪ trials using separate 2 ϫ 15 mixed factorial ANOVAs varying group (low vs. high) and trials (1-15). The results found a significant main effect of Group for gapes to the CSϩ (F 10,1 ϭ 9.55, p Ͻ .01), Figure 4A , but not to the CSϪ (F 10,1 ϭ 3.34, p ϭ .10); Figure 4C . The Group x Trial interaction was not significant for responding during the CSϩ condition (F 140,14 ϭ 1.27, p ϭ .24). With the exception of Trial 14, however, This document is copyrighted by the American Psychological Association or one of its allied publishers. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
the results of the 1-way ANOVAs revealed that high drug takers made more gapes to the CSϩ solution than did low drug takers following a single CSϩ-cocaine pairing, ps Ͻ .05 ( Figure 4B ). For the CSϪ data, a significant main effect of trial was obtained (F 140,14 ϭ 3.14, p Ͻ .001), indicating that the number of gapes to the CSϪ decreased across trials. Post hoc analysis of a significant Group ϫ Trial interaction (F 140,14 ϭ 3.26, p Ͻ .001) showed that high drug takers gaped more than low drug takers to the salineassociated taste cue, but only on CSϪ Trials 1, p Ͻ .01, and 2, p Ͻ .001, ( Figure 4D ). Given that training began with the CSϩ-cocaine trial for 9/12 subjects, the occurrence of gapes upon the first CSϪ trial, is interpreted as early generalization from the CSϩ to the CSϪ. Within-trial analysis of aversive taste reactivity. The temporal distribution of gaping behavior averaged across all 15 30-min I/O infusion sessions was then examined separately for the CSϩ and the CSϪ conditions using 2 ϫ 30 mixed factorial ANOVAs varying group (high vs. low drug takers) and IO infusions (1-30) as factors. For our analysis, gapes that occurred after Infusion 1 ended, but before Infusion 2 began, were included in the Infusion 1 count. As shown in Figure 5A , and confirmed by a significant main effect of group (F 24,1 ϭ 79.2, p Ͻ .001), the high drug takers made more gapes following the intraoral delivery of the CSϩ solution than did the low drug takers when collapsed across the 30 min CSϩ infusion session, overall. The main effect of infusion (F 696,29 ϭ 4.4, p Ͻ .001) and the Group ϫ Infusion interaction (F 696,29 ϭ 1.7, p Ͻ .001) were also significant. Follow-up t tests revealed that this difference was significant for each of 30 infusions, with the greatest number of gapes being emitted during infusions 6 -10 compared to infusions 1-5 (p Ͻ .05), 16 -20 (p Ͻ .001), 21-25 (p Ͻ .001), and 26 -30 (ps Ͻ .01) (Trials 6 -10 are indicated by a bracket in Figure 5A ).
Like responding for the CSϩ solution, the number of gapes emitted following the CSϪ infusion also differed between the low and the high drug takers (F 24,1 ϭ 7.2, p Ͻ .01, see Figure 5B ). However, the main effect of infusion (F Ͻ 1) and the Group ϫ Infusion interaction (F Ͻ 1) were nonsignificant. Even so, in an effort to be consistent with the analysis of the CSϩ data, follow-up t tests were conducted to compare the number of gapes emitted by the low and high drug takers on each infusion. The results showed that high drug takers gaped more than low drug takers during CSϪ IO infusions 1-3, 7, 22, 27, and 29 ( Figure 5B ). That said, and while this is evidence of some generalization between the CSϩ and the CSϪ solution, the high drug takers clearly exhibited far more gapes during the intraoral infusion of the CSϩ ( Figure 5A ) than during the intraoral infusion of the CSϪ ( Figure 5B ). Figure 6 summarizes the correlational data between aversive TR to the CSϩ (left panels) or the CSϪ (right panels) early in the This document is copyrighted by the American Psychological Association or one of its allied publishers. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
Early Aversive Taste Reactivity Predicts Cocaine-Taking
study with drug-related behavior at the end of the study. Neither Trial 1 nor Trial 2 gapes to the CSϩ reliably predicted drug-taking behavior. The following significant correlations were found between Trial 3 gapes to the CSϩ ( Figure 6 , left panels) and Trial 1 gapes to the CSϪ ( Figure 6 , right panels), and terminal drugtaking behaviors using a 1-tailed Pearson's correlation coefficient.
Terminal drug-taking was determined, as described, by averaging performance across the last two CSϩ or CSϪ trials.
Results showed that greater Trial 3 gapes to the CSϩ predicted greater terminal active spout responses, r ϭ .59, p Ͻ .05 ( Figure  6A ), greater terminal load-up infusions, r ϭ .63, p Ͻ .05 ( Figure  6E) , and a greater number of total terminal infusions, r ϭ .72, p Ͻ .01, ( Figure 6G ). Trial 1 gapes to the CSϪ (including data only from those rats for whom a CSϩ trial preceded the first CSϪ trial) predicted number of terminal active spout responses, r ϭ .96, p Ͻ .0001, (Figure 6B ), terminal log10 latency to first infusion, r ϭ Ϫ.68; p Ͻ .05, (Figure 6D ), terminal load-up infusions, r ϭ .88; p Ͻ .001, (Figure 6F) , and terminal infusions, r ϭ .93, p Ͻ .001, ( Figure 6H ). Finally, gapes emitted to the CSϩ on Trial 3 were highly correlated with the number of gapes emitted to the CSϪ on Trial 1, r ϭ .75, p Ͻ .003 (data not shown).
Discussion
In the present study, we report that rats who ultimately became high drug takers emitted greater aversive taste reactivity behavior (i.e., gaped more frequently) following a single taste-drug pairing than did rats that ultimately became low drug takers. Moreover, correlational analyses show that those rats that exhibited the most aversive TR upon their third exposure to the drug-paired taste cue exhibited the greatest responsiveness to drug as assessed during the last two self-administration trials. Specifically, gapes to the CSϩ following two taste-drug pairings (i.e., on the third CSϩ trial) reliably predicted operant responding for drug, load-up infusions, and total cocaine infusions in the last two cocaine selfadministration periods. Likewise, the first intraoral infusion of the CSϪ elicited a similar pattern of aversive TR behavior and this was highly predictive of later drug seeking and taking. Aversive taste reactivity to a drug-paired cue, then (via direct pairing or via generalization to the explicit drug-paired cue), occurs very early in training and, importantly, predicts later drug seeking and drug taking.
So, why is the drug-paired taste cue eliciting aversive tastereactivity behavior in the present experiment? Rats prefer a context that has been paired with cocaine and they readily self-administer the drug (Ahmed & Koob, 1998; Pettit, Ettenberg, Bloom, & Koob, 1984) . Cues coincidentally paired with drugs of abuse elicit approach behaviors and they support a conditioned increase in levels of dopamine in the nucleus accumbens (Weiss et al., 2001; Wheeler et al., 2011) . Finally, the intraoral delivery of a taste cue paired closely in time with experimenter administered cocaine, phencyclidine, or methamphetamine elicits little to no aversive TR (Parker, 1993) . In an effort to square this circle, we look to the literature and, in particular, to one recent report. Specifically, it was recently shown that a drug-paired taste cue (like that employed here) can elicit either conditioned reward or conditioned aversion, depending upon when the cue is delivered relative to drug infusion (Wheeler et al., 2011) . Thus, in agreement with the above-mentioned literature showing evidence for conditioned reward, the intraoral infusion of a gustatory CS that had previously been paired with the simultaneous intravenous infusion of selfadministered cocaine elicited evidence of a positive state involving ingestive, rather than aversive, taste reactivity behavior (i.e., licks rather than gapes) and a conditioned increase in dopamine in the nucleus accumbens. On the other hand, the very same gustatory cue elicited the onset of a negative affective state marked by aversive TR, reduced dopamine levels in the nucleus accumbens, and an elevated threshold for intracranial self-stimulation when the taste cue was infused once/min for 45 min prior to the opportunity to self-administer cocaine. This latter procedure is that which was employed here. Taken together, the data indicate that conditioned aversion does not depend upon rewarding and/or aversive properties of the drug (Arthurs, Lin, Amodeo, & Reilly, 2012) per se, or upon a subject's relative sensitivity to those properties (Verendeev & Riley, 2012) , because the drug in the Wheeler et al. manuscript (2011) was the same whether presented coincident with the gustatory cue or following presentation of the gustatory cue. Rather, the data suggest, and we conclude, that conditioned aversion depends upon the nature of the predictive relationship between the This document is copyrighted by the American Psychological Association or one of its allied publishers. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
cue and the consequence and the underlying physiology that supports that relationship. As alluded to in the Introduction, the conditioned aversive state elicited by cued anticipation of drug availability may reflect the development of an aversive opponent process involving conditioned withdrawal. As such, the CSϩ may serve as an occasion setter or discriminative stimulus that elicits conditioned compensatory responses in anticipation of drug (Ramos, Siegel, & Bueno, 2002; Siegel, 2001) . In accordance, like drug-induced avoidance of the gustatory cue, cue-induced withdrawal also is accompanied by elevated corticosterone (Nunez et al., 2007) , blunted dopamine in the nucleus accumbens (Shaham & Stewart, 1995) , and aversive TR behavior following the intraoral delivery of a naloxone-paired saccharin cue (McDonald et al., 1997) . Thus, while drug seeking and taking may be promoted by positive reinforcement, it also is promoted by negative reinforcement, as only drug serves to correct this conditioned aversive state (Solomon & Corbit, 1973 , 1974 Wheeler et al., 2011) . In accordance, in rats, greater conditioned avoidance/aversion is associated with greater drug seeking, greater load-up behavior, and greater drug taking (Grigson, & Twining, Figure 6 . Gapes emitted to the CSϩ on Trial 3 (left panels) and to the CSϪ on Trial 1 (right panels) for the low and high drug takers as a function of terminal active spout responses (panels A and B), terminal log10 latency to make the first cocaine infusion (panels C and D), terminal load-up infusions (panels E and F), and terminal infusions (panels G and H) during Trials 14 and 15. This document is copyrighted by the American Psychological Association or one of its allied publishers.
2002; Wheeler et al., 2011 Wheeler et al., , 2008 . In humans, negative affect also is evident when waiting for access to nicotine in the presence of drug-related cues (Sayette et al., 2003) and a failure to respond to monetary rewards, as indicated by blunted fMRI activity of the nucleus accumbens, predicts a short latency to choose a cigarette over money in a subsequent choice test (Wilson et al., 2013) . Our data indicate that for rats who became high drug takers, the CSϩ acquired significant occasion-setting properties after only one pairing with cocaine. This seems to fit well with evidence that a single taste-morphine pairing was sufficient to produce conditioned avoidance of the drug-paired taste cue and a conditioned blunting of the accumbens dopamine response to the otherwise palatable saccharin cue in rats (Grigson & Hajnal, 2007) . It also has been shown that a single pairing of environmental cues with cocaine self-administration is sufficient to produce CS-induced reinstatement of cocaine-seeking behavior when rats are exposed to a 1 h extinction test 9 months later (Ciccocioppo, MartinFardon, & Weiss, 2004) . Finally, like rats, adolescent humans can reportedly lose control over tobacco (i.e., exhibit symptoms of dependence) within a day or two of their first inhalation (DiFranza et al., 2007) and even one symptom of dependence strongly predicts continued use (DiFranza et al., 2002 ).
We would argue, then, that addiction can begin with the first exposure to drug and that this animal model provides not only a window on the development of this process, but a clear and very early indicator of individual vulnerability to, and resilience from, addiction. Thus, some drug-experienced rats exhibit greater avoidance of the taste cue, greater aversive TR behavior following the IO infusion of the drug-paired cue, greater conditioned elevation of corticosterone, and when challenged with naloxone, greater evidence for conditioned withdrawal (Gomez et al., 2000; Nyland & Grigson, 2013; Wheeler et al., 2008 ; see Figure 5 ). Where tested, these same rats then exhibit the shortest latency to take drug, the greatest load-up behavior, and the greatest seeking and taking of drug (Grigson & Twining, 2002; Nyland & Grigson, 2013) . Here, in our hands, aversive TR was found to occur very early and to predict later drug seeking and drug taking. Future studies will need to determine whether vulnerable individuals exhibit exaggerated conditioned responses early on because (1) the drug has a greater physiological impact upon first infusion in these subjects, (2) the palatable taste cue mitigates the impact of drug for some and less for others, or (3) a heightened regulatory process allows for the development of stronger conditioning of the opponent process (experienced as cue-induced withdrawal). Finally, we have identified a number of factors that affect avoidance of a drug-paired cue and/or responding for drug. For example, female SpragueDawley rats exhibit more acceptance of a cocaine-paired saccharin cue and less cocaine self-administration in the taste-drug model than male rats (Cason & Grigson, 2013) . Environmental enrichment during adulthood reduces acquisition of cocaine selfadministration in male rats (Puhl et al., 2012) . Chronic sleep deprivation, on the other hand, greatly augments acquisition of cocaine self-administration and the willingness to work for drug (Puhl, Boisvert, Guan, Fang, & Grigson, 2013; Puhl, Fang, & Grigson, 2009) , as does a history of having binged on fat (Puhl et al., 2011) . Thus, having identified an early indicator of vulnerability (i.e., conditioned aversive taste reactivity behavior to the drug-paired cue), future studies also will seek to intervene, behaviorally and/or pharmacologically, to prevent this early transition from use to abuse and addiction.
